In ovarian cancer models, the highly expressed adhesion molecule JAM3 can induce ferroptosis resistance by activating the NRF2/FSP1 signaling axis, providing important rationale for the use of FSP1 inhibitors as reversal agents (136). Here, AIFM2 is linked to ovarian carcinoma.